Tissue engineering (TE) is a technology that combines life sciences and engineering knowledge to restore and replace the functionality of impaired tissues and organs. However, the research work for tissue engineering has achieved limited success in engineering thick tissues. The goal of this work is to address two issues encountered in current technologies when creating 3D thick tissue structures. The major issue is vascularization or creating a 3D complex perfusable vasculature structure. Recently, an emerging solution is 3D bioprinting, a technology that integrates cells and bioinks (biomaterials) with an automated fabrication system such as a bioprinter. In 3D bioprinting, hydrogel, which is biocompatible with cells, is usually used as a cell carrier or bioink. However, most of hydrogels that have good biocompatibility have low printability or low mechanical strength. To solve this problem, a novel hydrogel composite has been developed which is both biocompatible and bioprintable. Separately, another issue in engineering thick tissues is the convenience in transfer and assembly of individual high cell density constructs such as cell laden hydrogels or cell sheets. In this research, another hydrogel composite, a biodegradable membrane modified with collagen gel has been developed to address this issue. A large part of this thesis focuses on the synthesis, characterization, 3D printing and modelling of a novel hydrogel composite-Pluronic-Gelatin methacrylate (Plu-GelMA). Pluronic needs to be modified into pluronic monocarboxylate (Plu-MP) before it can physically interact with GelMA. After synthesis, the Plu-GelMA hydrogel composites at different mass ratio are studied. A series of characterization have been performed, including chemical tests (NMR and FTIR),